Search research articles
Contact Us
Filters
Showing results (21-30 of 94) with videos related to
Page
of 10
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
August 12, 2010
Measuring consequences of protein misfolding and cellular stress using OMICS techniques
Peter Bross, Johan Palmfeldt, Jakob Hansen, et al.
Current Medicinal Chemistry
|
September 23, 2010
Emerging roles for riboflavin in functional rescue of mitochondrial β-oxidation flavoenzymes
Bárbara J Henriques, Rikke K Olsen, Peter Bross, et al.
FEBS Letters
|
January 12, 2011
A polymorphic position in electron transfer flavoprotein modulates kinetic stability as evidenced by thermal stress
Bárbara J Henriques, Mark T Fisher, Peter Bross, et al.
Gene
|
January 15, 2021
Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease
Bárbara J Henriques, Rikke Katrine Jentoft Olsen, Cláudio M Gomes, et al.
Plos One
|
November 3, 2011
Quantitative proteomics reveals cellular targets of celastrol
Jakob Hansen, Johan Palmfeldt, Søren Vang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
November 5, 2018
Deficiency of the mitochondrial sulfide regulator ETHE1 disturbs cell growth, glutathione level and causes proteome alterations outside mitochondria
Navid Sahebekhtiari, Paula Fernandez-Guerra, Zahra Nochi, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics
|
September 7, 2019
Potential complementation effects of two disease-associated mutations in tetrameric glutaryl-CoA dehydrogenase is due to inter subunit stability-activity counterbalance
Joana V Ribeiro, Tânia G Lucas, Peter Bross, et al.
The Journal of Biological Chemistry
|
December 18, 2008
Role of flavinylation in a mild variant of multiple acyl-CoA dehydrogenation deficiency: a molecular rationale for the effects of riboflavin supplementation
Bárbara J Henriques, João V Rodrigues, Rikke K Olsen, et al.
Pharmacogenomics
|
December 24, 2008
Drug-diagnostic codevelopment strategies: FDA and industry dialog at the 4th FDA/DIA/PhRMA/PWG/BIO Pharmacogenomics Workshop
Lois Hinman, Brian Spear, Zenta Tsuchihashi, et al.
International Journal of Molecular Sciences
|
June 3, 2020
Riboflavin Deficiency-Implications for General Human Health and Inborn Errors of Metabolism
Signe Mosegaard, Graziana Dipace, Peter Bross, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 94) with videos related to
Sort By:
Page
of 10
Methods in Molecular Biology (Clifton, N.J.)
|
August 12, 2010
Measuring consequences of protein misfolding and cellular stress using OMICS techniques
Peter Bross, Johan Palmfeldt, Jakob Hansen, et al.
Current Medicinal Chemistry
|
September 23, 2010
Emerging roles for riboflavin in functional rescue of mitochondrial β-oxidation flavoenzymes
Bárbara J Henriques, Rikke K Olsen, Peter Bross, et al.
FEBS Letters
|
January 12, 2011
A polymorphic position in electron transfer flavoprotein modulates kinetic stability as evidenced by thermal stress
Bárbara J Henriques, Mark T Fisher, Peter Bross, et al.
Gene
|
January 15, 2021
Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease
Bárbara J Henriques, Rikke Katrine Jentoft Olsen, Cláudio M Gomes, et al.
Plos One
|
November 3, 2011
Quantitative proteomics reveals cellular targets of celastrol
Jakob Hansen, Johan Palmfeldt, Søren Vang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
November 5, 2018
Deficiency of the mitochondrial sulfide regulator ETHE1 disturbs cell growth, glutathione level and causes proteome alterations outside mitochondria
Navid Sahebekhtiari, Paula Fernandez-Guerra, Zahra Nochi, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics
|
September 7, 2019
Potential complementation effects of two disease-associated mutations in tetrameric glutaryl-CoA dehydrogenase is due to inter subunit stability-activity counterbalance
Joana V Ribeiro, Tânia G Lucas, Peter Bross, et al.
The Journal of Biological Chemistry
|
December 18, 2008
Role of flavinylation in a mild variant of multiple acyl-CoA dehydrogenation deficiency: a molecular rationale for the effects of riboflavin supplementation
Bárbara J Henriques, João V Rodrigues, Rikke K Olsen, et al.
Pharmacogenomics
|
December 24, 2008
Drug-diagnostic codevelopment strategies: FDA and industry dialog at the 4th FDA/DIA/PhRMA/PWG/BIO Pharmacogenomics Workshop
Lois Hinman, Brian Spear, Zenta Tsuchihashi, et al.
International Journal of Molecular Sciences
|
June 3, 2020
Riboflavin Deficiency-Implications for General Human Health and Inborn Errors of Metabolism
Signe Mosegaard, Graziana Dipace, Peter Bross, et al.
Page
of 10